Strategic acquisitions Sightpath has expanded through acquisitions such as PennVista in 2024 and Accusite Surgical in 2022, indicating a growth strategy that could open opportunities for cross-selling upgraded equipment, integration services, and bundled ophthalmic solutions to newly acquired facilities.

Mobile surgery leadership With a history of mobile ophthalmic services and the MoFe mobile laser suite, Sightpath values portable, on-site capability. This suggests a sales angle around portable or compact ophthalmic equipment, service contracts, and remote maintenance for practices expanding outreach.

Partnership potential Recent partnership with IQity signals openness to technology collaborations. Engage in joint solution opportunities combining Sightpath’s equipment access with IQity’s tech offerings to enhance surgical workflows and data analytics across 1300+ surgeon customers.

Broad customer base Serving over 850 facilities and 1300 surgeons nationwide indicates a large installed base. Target expansion through service contracts, consumables, training programs, and parts supply to deepen customer stickiness and increase recurring revenue.

Digital and CRM readiness Adoption of Microsoft 365, Google Cloud, Salesforce Marketing Cloud and other platforms shows a modern tech stack. Leverage this for targeted marketing, data-driven account-based selling, and seamless ordering and service ticket experiences for ophthalmic practices.